Acquisition adds 255,000 sq. ft. to UPS’ European network of facilities
Continuing the build-or-buy expansion program that UPS Healthcare Logistics has been on for several years, the company has acquired CEMELOG, based near Budapest, for an undisclosed price. The transaction is expected to close this quarter. The company, founded in 1999, has three facilities and distributes to hospitals, pharmacies and wholesalers in Central and Eastern Europe.
Although the acquisition is taking place after the failed bid by UPS to obtain regulatory clearance to acquire TNT Express, an international express-delivery company, late last year, the CEMELOG purchase is not a reaction to that bid. Bill Hook, president of UPS Healthcare Logistics, says that the discussions were already under way in mid-2012. “If anything, the TNT outcome just means that we can do these tuck-in acquisitions more quickly,” he says.
In part, the acquisition mirrors that of Pieffe, an Italian regional healthcare distributor UPS acquired in 2011. “That integration has proceeded very smoothly,” say Hook, “and in some ways, it shows us that we can move even faster with these regional integrations into our network.”
UPS now has 41 facilities worldwide (not including CEMELOG), representing over 6.4 million sq. ft of dedicated healthcare space. Hook says that as the network expands globally, it provides a more effective “platform” for companies to develop new models of distribution and multi-channel services to healthcare systems worldwide.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.